Press release
Rising Chronic Respiratory Diseases and Technological Innovations Drive Growth in the Aptamers Technology Market
The Aptamers Technology market is expected to grow from an estimated USD 2.2 billion in 2024 to USD 16.4 billion in 2033, at a CAGR of 25.00%. The global aptamers technology market is set to experience significant growth, driven by the increasing prevalence of chronic respiratory diseases and advancements in personalised medicine. Aptamers, short DNA or RNA molecules that bind to specific targets, are proving to be a game-changer in diagnostics and treatment.Chronic respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD), are on the rise, creating a strong demand for advanced diagnostic and therapeutic solutions. Aptamers play a crucial role in detecting respiratory syncytial virus (RSV) and facilitating early disease diagnosis. According to the Asthma and Allergy Foundation of America, over 25 million Americans were diagnosed with asthma as of May 2021, highlighting the urgent need for advanced healthcare solutions. The growing burden of such conditions is expected to fuel the demand for aptamer-based technologies.
Additionally, the increasing focus on personalised medicine is propelling market expansion. Personalised medicine tailors treatments to individual patient profiles based on genetics, lifestyle, and environmental factors. Aptamers are playing a key role in this domain, offering highly specific binding to targeted molecules. As per The Personalized Medicine Coalition, the FDA's Center for Drug Evaluation and Research (CDER) approved 50 new molecular entities in 2021, with 35% classified as personalised medicines. This shift towards precision medicine is expected to drive the aptamers market forward.
Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.emergenresearch.com/request-sample/3611
Technological Advancements Boost Market Growth
Innovation in aptamer technology is enhancing the efficiency and stability of these molecules, making them highly effective for various applications. Improvements in nucleic acid chemistry and high-throughput screening techniques are allowing for faster identification of targeted molecules, accelerating research and development efforts. These advancements are expanding the scope of aptamers in diagnostics and therapeutics.
A notable example of innovation in this space is the development of artificial DNA aptamers by NEC Corporation in Japan. In May 2021, NEC successfully created aptamers capable of binding to SARS-CoV-2, the virus responsible for COVID-19. These aptamers effectively target the virus's receptor-binding domain (RBD), demonstrating their potential in combating infectious diseases. As technological advancements continue, aptamers are expected to find broader applications in customised medicine and targeted therapies.
Challenges Hindering Market Growth
Despite the promising outlook, limited awareness and acceptance of aptamer technology pose challenges to market expansion. Many healthcare professionals and researchers are yet to fully understand the benefits of aptamers over traditional antibodies. This lack of familiarity results in slow adoption within clinical and research settings. Additionally, misconceptions about aptamers' reliability and effectiveness contribute to hesitation among potential users.
To overcome these barriers, educational initiatives and awareness campaigns must be implemented to promote the advantages of aptamers. Increased outreach efforts can help accelerate adoption and integration into mainstream healthcare and research applications.
Requesting A Customised Report @https://www.emergenresearch.com/request-for-customization/3611
Market Segmentation and Future Outlook
The aptamers technology market is segmented by application, including Therapeutics Development, Research & Development, and Diagnostics. The research and development sector accounted for the largest market share in 2023, driven by growing demand for aptamers and rising research activities. Strategic collaborations between key industry players are fostering innovation in aptamer-based diagnostics and therapeutics. For instance, in June 2021, SomaLogic and Ixaka Ltd entered into a research agreement to develop aptamer-based bispecific therapies, further strengthening the market.
The therapeutics development segment is projected to grow at the highest compound annual growth rate (CAGR) between 2023 and 2030. The ability to design aptamer-based antidotes, which is challenging with antibodies, positions aptamers as a superior alternative to protein therapeutics. Their synthetic accessibility, small size, and ability to undergo chemical modifications make them highly promising for future medical applications. However, concerns regarding nuclease resistance remain a key challenge, which may impact market growth.
As the demand for targeted therapies and advanced diagnostics rises, the aptamers technology market is expected to expand significantly. With ongoing research, technological advancements, and increasing awareness, aptamers are set to revolutionise modern medicine and healthcare.
To Read More About The Report, Visit @https://www.emergenresearch.com/industry-report/aptamers-technology-market
Aptamers Technology Top Companies and Competitive Landscape
The aptamers technology industry involves the development and application of aptamers, short single-stranded nucleic acids that can bind to specific targets: proteins, small molecules, and even cells. Aptamers technology is fast gaining popularity in diagnostics, therapeutics, and research due to its proven specificity and stability compared to traditional antibodies.
Some of the key players in the market are Aptamer Group, Raptamer Discovery Group, SomaLogic Inc., and Aptamer Sciences, Inc., which are leaders in developing innovative aptamer-based solutions. Rising demand for targeted therapies and personalised medicine, along with progress in nucleic acid chemistry, is fueling growth in the market. The scope for this sector will grow dramatically as more applications of aptamers are found and developed in health and biotechnology.
In March 2024, Aptamer Group plc, a leading aptamers company, announced the development of a new reagent to improve automated immunohistochemistry (IHC) workflow. The Optimer®-Fc tool is an excellent example of how aptamers may be used to provide unique solutions in the healthcare business.
Some of the key companies in the global Aptamers Technology market include:
Aptamer Group
Raptamer Discovery Group
SomaLogic Inc.
Aptamer Sciences, Inc.
Aptagen, LLC
Maravai Lifesciences
Kaneka Corporation
NeoVentures Biotechnology Inc.
Aptus Biotech
Base Pair Biotechnologies
AMSBIO
Novaptech
Bio-Techne
Aptamers Technology Latest Industry Updates
In January 2023, Aptamer Group cooperated with BaseCure Therapeutics to create Optimer-targeted medicines. Such projects have the potential to expand the use of aptamers in medicinal applications.
In March 2022, Aptamer Sciences has chosen a candidate material for the "Corona-19 virus neutralising aptamer," which will support non-clinical efforts in COVID-19 treatment and vaccine development.
To Purchase Now, Click Here @https://www.emergenresearch.com/select-license/3611
Aptamers Technology Market Segmentation Analysis
Туре Outlook (Revenue, USD Billion; 2020-2033)
DNA Aptamers
XNA Aptamers
RNA Aptamers
Technology Outlook (Revenue, USD Billion; 2020-2033)
SELEX
Others
Application Outlook (Revenue, USD Billion; 2020-2033)
Therapeutics Development
Research & Development
Diagnostic
Others
End User Outlook (Revenue, USD Billion; 2020-2033)
Pharmaceutical & Biotechnology Companies
Academic & Government Research Institutes
CROS
Others
Regional Outlook (Revenue, USD Billion; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Read More Related Report
Aptamers Technology Market Size @ https://www.emergenresearch.com/industry-report/aptamers-technology-market/market-size
Aptamers Technology Market Share @ https://www.emergenresearch.com/industry-report/aptamers-technology-market/market-share
Aptamers Technology Market Trends @ https://www.emergenresearch.com/industry-report/aptamers-technology-market/market-trends
Aptamers Technology Regional Market Demand @ https://www.emergenresearch.com/industry-report/aptamers-technology-market/regional-market-demand
Aptamers Technology Market Analysis @ https://www.emergenresearch.com/industry-report/aptamers-technology-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Chronic Respiratory Diseases and Technological Innovations Drive Growth in the Aptamers Technology Market here
News-ID: 3854787 • Views: …
More Releases from Emergen Research

Global Digital Process Automation Market Set for Rapid Growth, Expected to Reach …
The Digital Process Automation (DPA) market is projected to experience substantial growth, increasing from an estimated USD 14.5 billion in 2024 to USD 41.9 billion by 2033, at a compound annual growth rate (CAGR) of 12.5%. The rising need for businesses to enhance efficiency, streamline operations, and improve customer service is fueling this expansion.
Market Growth Drivers
Businesses across industries are increasingly turning to digital automation to reduce costs, minimize human error,…

Global Styrene Butadiene Rubber (SBR) Market Set to Reach USD 70.6 Billion by 20 …
The global Styrene Butadiene Rubber (SBR) market is projected to grow from USD 47.5 billion in 2024 to USD 70.6 billion by 2033, at a steady compound annual growth rate (CAGR) of 4.5%. The increasing demand for SBR in the footwear and automotive industries is driving market expansion.
Growth in Footwear Industry Fuels SBR Demand
The rising demand for comfortable, durable, and flexible footwear is a key factor contributing to the growth…

Global Desktop Virtualization Market Set for Rapid Growth, Expected to Reach USD …
The global desktop virtualization market is on a significant growth trajectory, projected to rise from USD 13.25 billion in 2024 to USD 35.3 billion by 2033, at an impressive compound annual growth rate (CAGR) of 11.5%.
Market Growth Driven by Remote Work and Cloud Adoption
The increasing adoption of remote work and cloud-based services is fueling the expansion of the desktop virtualization market. Businesses are investing in Virtual Desktop Infrastructure (VDI), Desktop-as-a-Service…

Global Steel Market 2024 Emerging Industry Trends and Dynamics with Prominent Pl …
The global steel market is projected to experience substantial growth, rising from an estimated USD 1,954.5 billion in 2024 to USD 3,032.1 billion by 2033, at a compound annual growth rate (CAGR) of 5.00%. This growth is primarily fueled by government infrastructure investments, rising demand in key industries, and advancements in steel technology.
Infrastructure Development Driving Demand
Governments worldwide are significantly investing in large-scale infrastructure projects, including transportation networks, buildings, and energy…
More Releases for Aptamer
SELEX Aptamer Selection Process to be the Gold Standard Selection Technique in A …
Though currently limited to the pharmaceutical industry, intense research & development initiatives taken by players in the aptamer market are projected to broaden the existing scope of application of these neoteric molecules to create horizontal market opportunities. With enhanced properties, aptamers are likely to play a pivotal role in environmental monitoring and quality control applications in the agriculture industry.
Click here to Get Synopsis of the Report https://www.factmr.com/report/173/aptamers-market
Currently, a significant volume…
Aptamers Market 2020-2026 to Witness Exponential Growth || Key Players - Aptamer …
The market data analysed and evaluated in this Aptamers Market business document makes to achieve the business goals and objectives in preset time frame. Moreover, Global Aptamers business document encompasses all the company profiles of the major players and brands. The report offers a thorough synopsis on the study, analysis and estimation of the market and how it is impacting the industry. To prepare this Aptamers Market report, detailed market…
Global Aptamers Market - Industry Trends - Forecast to 2026 || Leading Players - …
Staying informed about the trends and opportunities in the industry is quite a time consuming process where this Aptamers Market report actually helps a lot. The major areas of market analysis such as market definition, market segmentation, competitive analysis and research methodology are studied very carefully and precisely in the whole Aptamers Market report. Various steps are used while generating this report by taking the inputs from a specialized team…
What's Driving Aptamers Market Trends? Key Company Profiled In LLC, Aptagen, LLC …
Aptamers are oligonucleotides or peptide molecules that bind to target lipid, protein, or nucleic acid molecules with a high specificity. Aptamers are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be engineered to have higher affinity and specificity to large number of targets.…
Aptamer Market Scope, On-Going Trends, Demand, Leading Players, Manufactures (AM …
Aptamers are known as special class of molecules which combine the benefits of both low molecular weight as well protein molecules. Over the years, these molecules have fascinated several researchers who are active in various fields of science ranging from analytical chemistry to medicine. To study the overall market expanse for aptamer, a new research study has been added to the broad database of Market Research Reports Search Engine (MRRSE).…
Aptamer Market 2018 Analysis and Growth by Top Key Players- NewVentures Biotechn …
The report “Global Aptamer by Manufacturers, Regions, Type and Application” highlights key dynamics of Aptamer Market. The potentiality of this sector has been examined along with the significant challenges and growth opportunities. The present market scenario and future predictions of the sector has also been studied in-depth in this report. The report also provides the key market players that are assessed on numerous parameters such as manufacturer’s summary, revenue generation,…